Novo Nordisk Leads in Diabetes and Obesity Drugs, Zealand Pharma Stock Soars on Liver Disease Drug Trial, Bitcoin Nears $60K, Millennials Poised for Wealth Transfer in Coming Decade

Novo Nordisk is the current market leader for diabetes and obesity drugs.

Zealand Pharma stock soared over 34% due to positive trial results for a liver disease drug that is also being tested for weight loss.

The price of Bitcoin has risen 15% in just four days to $59,396.

A massive transfer of wealth is set to take place over the next decade, with millennials set to come out on top and invest differently than previous generations.

The Winklevoss twins reached a $1.1 billion settlement agreement with the New York State Department of Financial Services related to their cryptocurrency exchange Gemini.